Important note: Information in this article was accurate in 1988. The state of the art may have changed since the publication date.
SAN FRANCISCO CHRONICLE (SF) - THURSDAY October 13, 1988 Edition: FINAL Section: NEWS Page: A27 Word Count: 299
David Perlman, Chronicle Science Editor
The universities are among seven chosen around the country as "centers of excellence" to share in more than $30 million committed over the next five years to find new treatments for acquired immune deficiency syndrome and, ultimately, a vaccine.
At the University of California at San Francisco, the center will be directed by Dr. Paul Volberding, who heads the AIDS program at San Francisco General Hospital, and Dr. John L. Ziegler, chief of AIDS research at the Veterans Administration Hospital.
Its main purpose, according to Volberding, will be to expand existing research now being conducted by more than 150 scientists on the UCSF campus, at the two hospitals, in the city's health department and the UC School of Public Health in Berkeley.
At Stanford Medical School, the center will be directed by Dr. Thomas Merigan. He said the main focus will be "developing new agents - drugs or biologics, including vaccines - that can treat or help prevent infection by HIV, the AIDS virus.
"This is the glue that can hopefully bind together many of our research projects already under way."
At UC Davis, the center will be directed by Dr. Murray B. Gardner, chief of pathology in the medical school. Three major groups focusing on clinical and molecular virology and primate research will be seeking to understand the natural history of AIDS in monkeys and cats. They will use animal models in the hope of developing new anti-viral therapies and vaccines.
The other centers announced yesterday are at Purdue University, the University of Washington, the University of Alabama and the Albert Einstein College of Medicine in New York.
Copyright © 1988 - San Francisco Chronicle Press. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the San Francisco Chronicle, Permissions Desk, 901 Mission Street, San Franciso, CA 94103. You may also send a fax to (415) 495-3843, or an email message to chronperm@sfgate.com. http://www.sfgate.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1988. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1988. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .